Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.

Also called NCT07324031

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
AtaCor Medical, Inc. (from the registry)
Registry
  • NCT NCT07324031
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Netherlands (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07324031. Allocation not applicable; no masking; primary purpose treatment. Start 2026-07-02 (actual); primary completion 2027-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
Acronym
ALARION EV
Condition
Ventricular Arrythmia
Condition
Ventricular Tachycardia
Intervention (Device)
Atala™ lead and EV-ICD Pulse Generator
Lead sponsor
AtaCor Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07324031
Content hash
15508e01e7bbe2ddc353fcb52d1de963ad0a15f5f652d6dd60e9fe63307a29f9